Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12168056
Scintillator nanocrystal-containing compositions and methods for their use
granted -
US 12161672
Chimeric antigen receptor and methods of use thereof
granted -
US 12161648
Covalent targeting of E3 ligases
granted -
US 12163148
Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9
granted -
US 12162950
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted -
US 12162870
Anticancer compounds
granted -
US 12161664
Tetrathionate for cyanide and methylmercaptan poisoning
granted -
US 12156877
Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor
granted -
US 12156893
Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto
granted -
US 12157778
Peptides for activation of cell signaling in osteoprogenitor cells
granted -
US 12144826
Methods of treating EGFRvIII expressing glioblastomas
granted -
US 12144843
Methods and compositions for modulating myofibroblast activities
granted -
US 12145925
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 12139531
Compositions and methods useful in promoting milk production
granted -
US 12139470
Trioxolane agents
granted -
US 12134651
Anti-Ryk antibodies and methods of using the same
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12123015
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12115183
Synthetic melanin nanoparticles and uses thereof
granted -
US 12116375
Compositions and methods for treating cancer
granted -
US 12110334
Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
granted -
US 12109231
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109230
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109229
Treatment of neurodegenerative disease with sodium chlorite
granted